Hydroxy lenalidomide

• Description :

  Hydroxy lenalidomide (5-Hydroxy lenalidomide) is a metabolite of lenalidomide that is present as a minor component in plasma and excreta, accounting for less than 5% of the total radioactivity, following oral administration of lenalidomide in healthy male subjects.

• Product Name Alternative :

  5-Hydroxy lenalidomide

• UNSPSC :

  12352005

• Hazard Statement :

  H302

• Target :

  Drug Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/hydroxy-lenalidomide.html

• Smiles :

  O=C1NC(C(CC1)N2C(C3=CC=C(C(N)=C3C2)O)=O)=O

• Molecular Formula :

  C13H13N3O4

• Molecular Weight :

  275.26

• Precautions :

  P264-P270-P330-P501

• References & Citations :

  [1]Pharmacokinetics, metabolism and excretion of [ (14) C]-lenalidomide following oral administration in healthy male subjects

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 3

• CAS Number :

  [1421593-78-3]